Butyrate Conditions Human Dendritic Cells to Prime Type 1 Regulatory T Cells via both Histone Deacetylase Inhibition and G Protein-Coupled Receptor 109A Signaling
Year: 2017
Type: article
Abstract: Recently it has become clear that short chain fatty acids (SCFAs), and in particular butyrate, have anti-inflammatory properties. Murine studies have shown that butyrate can promote regulatory T cells (Tregs) via the induction of tolerogenic dendritic cells (DCs). However, the effects of SCFAs on human DCs and how they affect their capacity to prime and polarize T cell responses has not been addressed. Here we report that butyrate suppresses LPS-induced maturation and metabolic reprogramming of human monocyte-derived DCs (moDCs) and conditions them to polarize naive CD4+ T cells towards IL-10-producing type 1 regulatory T cells (Tr1). This effect was dependent on induction of the retinoic acid-producing enzyme retinaldehyde dehydrogenase 1 (RALDH1) in DCs. The induction of RALDH activity and Tr1 cell differentiation by butyrate was dependent on simultaneous inhibition of histone deacetylases (HDACs) and signaling through G protein-coupled receptor (GPR)109A. Taken together, we reveal that butyrate is a potent inducer of tolerogenic human DCs, thereby shedding new light on the cellular and molecular mechanisms through which SCFAs can exert their immunomodulatory effects in humans.
Source: Frontiers in Immunology
Institutions: Leiden University Medical Center, University of Indonesia
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: butyrate, short-chain fatty acids, dendritic cells, type 1 regulatory T cells, tolerogenic dendritic cells, histone deacetylase inhibition, GPR109A, retinoic acid, monocyte-derived dendritic cells, dendritic cell maturation, metabolic reprogramming, IL-10, CD4+ T cell polarization, immunomodulation, anti-inflammatory activity
Open Access status: gold
Estimated APC paid: $3,801
Award: G6678691800
OpenAlex ID: W2765924996
